Skip to search formSkip to main contentSkip to account menu

morniflumate

Known as: 3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 2-(4-morpholinyl)ethyl ester, beta-morpholinoethyl niflumate, niflumic acid beta-morpholinoethyl ester 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Niflumic Acid
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Efficacy and Safety of Morniflumate for the Treatment of Symptoms Associated with Soft Tissue Inflammation
The effectiveness of nonsteroidal antiinflammatory drugs (NSAIDs) for the management of pain in osteoarthritis and other… 
2013
2013
Simultaneous determination of morniflumate and its major active metabolite, niflumic acid, in human plasma by high-performance liquid chromatography in stability and pharmacokinetic studies.
A rapid, sensitive and stable high-performance liquid chromatography (HPLC) method was developed and validated for the… 
2010
2010
Effects of perioperative intravenous low dose of ketamine on postoperative analgesia in children
Background and objective Low dose of ketamine reduces postoperative pain and opioid consumption in adult studies. However, there… 
2001
2001
Controlled, double-blind, randomized comparison of nimesulide β-cyclodextrin and morniflumate in acute otitis
1998
1998
Morniflumate‐induced urticaria‐angioedema
M is the morpholinoethyl ester of niflumic acid, a nonsteroidal anti-inflammatory drug (NSAID) in the antranihc acid group… 
1990
1990
Double-Blind, Placebo-Controlled Multicentre Trial of the Efficacy and Tolerance of Morniflumate Suppositories in the Treatment of Tonsillitis in Children
The efficacy and tolerability of morniflumate suppositories used together with phenoxymethylpenicillin were studied in a placebo… 
1990
1990
[Efficacy and tolerability of morniflumate in acute otitis in infants: results of a randomized study versus placebos].
In a randomized double-blind placebo-controlled, parallel group study, 79 infants with acute otitis media received treatment with… 
1990
1990
[Treatment of acute inflammatory pathology of the upper airway with morniflumate].
Sixty patients, 33 men and 27 women (mean age about 45 years; range 25-60), affected by acute influenza syndrome of the upper… 
1984
1984
Gastroprotective effects of morniflumate, an esterified anti-inflammatory drug.
An experimental study on morniflumate, the beta-morpholinoethyl ester of niflumic acid, was undertaken in the rat to test its… 
1984
1984
A gastroprotective anti-inflammatory agent: theβ-morpholinoethyl ester of niflumic acid (morniflumate)
In several animal models orally administered morniflumate, the β-morpholinoethyl ester of niflumic acid, proved almost equal to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)